let’s craft your future – empowering talent
101 Main Street, Queens, New York
United States – 11435
+1 (800) 555 5555
[Monday to Friday | 9:00 AM – 6:00 PM]
send a message
Head Office
101 Main Street, Queens, New York,
United States - 11435
frequently asked questions
Patients and caregivers should be informed that:
- Epitilia is a food supplement
- It does not treat epilepsy
- It does not replace prescribed medication
- It is intended to complement a balanced diet during ongoing medical care
Clear and transparent communication is essential.
The published study evaluating the formulation included pediatric patients and reported good tolerability in this population.
Use in children should always follow the guidance of a healthcare professional.
Epitilia may be considered as:
- nutritional support
- complementary supplementation
- part of a balanced diet within a medically supervised care plan
Epitilia should not be presented as a treatment for epilepsy or seizure disorders.
In the published study, the formulation was administered alongside standard medical therapy without reported compatibility concerns.
However, individuals receiving medical treatment should always consult their healthcare professional before starting any food supplement.
In the published study, the formulation was administered for several months and was reported to be well-tolerated.
As with all food supplements, long-term use should be assessed by a healthcare professional on an individual basis.
No. Epitilia is a food supplement and must not replace prescribed antiepileptic medication or medical treatment.
It is intended only as a complementary nutritional formulation and should be used as part of a medically supervised care plan.
The study evaluated parameters including:
- overall tolerability
- gastrointestinal comfort
- markers related to oxidative balance
- quality-of-life-related measures
These observations were made while patients continued their standard medical therapy.
The study did not evaluate Epitilia as a treatment for epilepsy.
Yes. The Epitilia range includes formulations designed for both children and adults.
Epitilia Adults follows the same formulation concept with adjusted nutrient levels tailored for adult nutritional requirements.
Yes. In the published study, the formulation was administered alongside stable medical therapy.
The study evaluated tolerability and compatibility with ongoing treatment without modifying the prescribed medical regimen.
As with any supplement, use should always follow medical advice.
The formulation of Epitilia is based on ingredients that have been individually studied and are commonly used in food supplements supporting normal physiological functions.
A published clinical study evaluated the same formulation (Epilamba) alongside standard medical care in pediatric patients. The study primarily assessed safety, tolerability, and quality-of-life-related parameters.
Epitilia does not claim therapeutic effects and should be used only as a food supplement within a medically supervised care plan.
Epitilia is intended for individuals who may benefit from additional nutritional support as part of a balanced diet.
Its use may be considered within a medically supervised care plan where maintaining nutritional balance and normal physiological functions is important.
Epitilia does not replace medical therapy and should always be used under healthcare professional supervision.
Epitilia formulations are food supplements formulated with selected vitamins and botanical extracts intended to support normal physiological functions, including nervous system function and energy metabolism.
It is designed to be used as part of a balanced diet and may be considered within a medically supervised care plan.
Epitilia is not a medicinal formulation and is not intended to diagnose, treat, cure, or prevent epilepsy or any other medical condition.
